"Proprietary Name","NDC Package Code","Strength","Dosage Form","Route","Appl. No.","Labeler Name","Product NDC","Nonproprietary Name","Substance Name","Product Type Name","Start Marketing Date","End Marketing Date","Market Category","Package Description","Pharm Class","DEA","Sample Package","Listing Record Certified Through:"
"Aplenzin","0187-5810-30","174 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022108","Bausch Health US, LLC","0187-5810","bupropion hydrobromide","BUPROPION HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","04/23/2008","N/A","NDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5810-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Aplenzin","0187-5810-07","174 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022108","Bausch Health US, LLC","0187-5810","bupropion hydrobromide","BUPROPION HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","04/23/2008","N/A","NDA","7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5810-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Aplenzin","0187-5811-07","348 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022108","Bausch Health US, LLC","0187-5811","bupropion hydrobromide","BUPROPION HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","04/23/2008","N/A","NDA","7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Aplenzin","0187-5811-30","348 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022108","Bausch Health US, LLC","0187-5811","bupropion hydrobromide","BUPROPION HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","04/23/2008","N/A","NDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Aplenzin","0187-5812-30","522 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022108","Bausch Health US, LLC","0187-5812","bupropion hydrobromide","BUPROPION HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","04/23/2008","N/A","NDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Aplenzin","0187-5812-07","522 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA022108","Bausch Health US, LLC","0187-5812","bupropion hydrobromide","BUPROPION HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","04/23/2008","N/A","NDA","7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"AUVELITY","81968-045-30","105 mg/1,                         45  mg/1","TABLET, MULTILAYER, EXTENDED RELEASE","ORAL","NDA215430","Axsome Therapeutics, Inc.","81968-045","dextromethorphan hydrobromide, bupropion hydrochloride","BUPROPION HYDROCHLORIDE;  DEXTROMETHORPHAN HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","08/18/2022","N/A","NDA","30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2026"
"AUVELITY","81968-045-31","105 mg/1,                         45  mg/1","TABLET, MULTILAYER, EXTENDED RELEASE","ORAL","NDA215430","Axsome Therapeutics, Inc.","81968-045","dextromethorphan hydrobromide, bupropion hydrochloride","BUPROPION HYDROCHLORIDE;  DEXTROMETHORPHAN HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","05/10/2024","N/A","NDA","1 BOTTLE in 1 CARTON (81968-045-31)  / 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","Yes","12/31/2026"
"AUVELITY","81968-045-60","105 mg/1,                         45  mg/1","TABLET, MULTILAYER, EXTENDED RELEASE","ORAL","NDA215430","Axsome Therapeutics, Inc.","81968-045","dextromethorphan hydrobromide, bupropion hydrochloride","BUPROPION HYDROCHLORIDE;  DEXTROMETHORPHAN HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","06/28/2024","N/A","NDA","60 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","No","12/31/2026"
"AUVELITY","81968-045-14","105 mg/1,                         45  mg/1","TABLET, MULTILAYER, EXTENDED RELEASE","ORAL","NDA215430","Axsome Therapeutics, Inc.","81968-045","dextromethorphan hydrobromide, bupropion hydrochloride","BUPROPION HYDROCHLORIDE;  DEXTROMETHORPHAN HYDROBROMIDE","HUMAN PRESCRIPTION DRUG","09/18/2024","N/A","NDA","1 BOTTLE in 1 CARTON (81968-045-14)  / 14 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA],  Sigma-1 Agonist [EPC],  Sigma-1 Receptor Agonists [MoA],  Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],  Uncompetitive NMDA Receptor Antagonists [MoA]","N/A","Yes","12/31/2026"
"bupropion","0615-8262-39","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8262","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/08/2019","02/28/2026","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8262-39)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","N/A"
"bupropion","63187-521-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Proficient Rx LP","63187-521","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-521-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","63187-521-60","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Proficient Rx LP","63187-521","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-521-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","63187-521-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Proficient Rx LP","63187-521","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-521-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","65841-780-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Lifesciences Limited","65841-780","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2014","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-780-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","65841-780-06","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Lifesciences Limited","65841-780","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2014","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-780-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","65841-780-10","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Lifesciences Limited","65841-780","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2014","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-780-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","65841-780-16","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Lifesciences Limited","65841-780","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2014","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-780-16)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","65841-836-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Lifesciences Limited","65841-836","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","65841-836-06","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Lifesciences Limited","65841-836","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","65841-836-10","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Lifesciences Limited","65841-836","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2018","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","65841-836-16","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Lifesciences Limited","65841-836","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2018","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-16)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","68382-353-06","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Pharmaceuticals USA Inc.","68382-353","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","68382-353-16","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Pharmaceuticals USA Inc.","68382-353","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2018","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-16)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","68382-353-10","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Pharmaceuticals USA Inc.","68382-353","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2018","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","68382-353-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Pharmaceuticals USA Inc.","68382-353","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","68382-354-16","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Pharmaceuticals USA Inc.","68382-354","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2014","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-16)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","68382-354-10","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Pharmaceuticals USA Inc.","68382-354","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2014","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","68382-354-06","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Pharmaceuticals USA Inc.","68382-354","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2014","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","68382-354-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA201567","Zydus Pharmaceuticals USA Inc.","68382-354","bupropion","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2014","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71205-565-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Proficient Rx LP","71205-565","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/11/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-565-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71205-565-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Proficient Rx LP","71205-565","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/11/2021","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-565-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71205-565-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Proficient Rx LP","71205-565","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/11/2021","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-565-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71335-0801-5","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Bryant Ranch Prepack","71335-0801","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/09/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71335-0801-4","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Bryant Ranch Prepack","71335-0801","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/09/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71335-0801-6","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Bryant Ranch Prepack","71335-0801","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/09/2024","N/A","ANDA","28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71335-0801-3","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Bryant Ranch Prepack","71335-0801","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/09/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71335-0801-1","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Bryant Ranch Prepack","71335-0801","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2018","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion","71335-0801-2","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","Bryant Ranch Prepack","71335-0801","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/09/2024","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion HCL","72189-457-30","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Direct_Rx","72189-457","Bupropion HCL","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/30/2023","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (72189-457-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion HCL ER (XL)","61919-558-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Direct_Rx","61919-558","Bupropion HCL ER (XL)","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-558-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion HCL ER (XL)","61919-558-72","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Direct_Rx","61919-558","Bupropion HCL ER (XL)","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/15/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-558-72)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion HCL ER (XL)","72189-539-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Direct_RX","72189-539","Bupropion HCL ER (XL)","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-539-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion HCL ER (XL)","72189-539-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Direct_RX","72189-539","Bupropion HCL ER (XL)","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-539-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0115-5445-13","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA076711","Amneal Pharmaceuticals of New York LLC","0115-5445","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/03/2004","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-5445-13)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0115-6811-10","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077415","Amneal Pharmaceuticals of New York LLC","0115-6811","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2009","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0115-6811-02","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077415","Amneal Pharmaceuticals of New York LLC","0115-6811","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2009","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0115-6811-08","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077415","Amneal Pharmaceuticals of New York LLC","0115-6811","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2009","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-08)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0591-3331-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Actavis Pharma, Inc.","0591-3331","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/26/2008","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3331-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Actavis Pharma, Inc.","0591-3331","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/26/2008","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3331-19","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Actavis Pharma, Inc.","0591-3331","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/26/2008","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-19)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3540-05","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Actavis Pharma, Inc.","0591-3540","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/02/2009","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3540-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3540-60","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Actavis Pharma, Inc.","0591-3540","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/02/2009","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3540-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3541-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Actavis Pharma, Inc.","0591-3541","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/02/2009","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3541-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3541-25","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Actavis Pharma, Inc.","0591-3541","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/02/2009","N/A","ANDA","250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3541-25)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3541-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Actavis Pharma, Inc.","0591-3541","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/02/2009","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3541-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3542-60","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Actavis Pharma, Inc.","0591-3542","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/02/2009","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3542-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3543-76","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079094","Actavis Pharma, Inc.","0591-3543","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/25/2009","N/A","ANDA","1 BOTTLE, PLASTIC in 1 CARTON (0591-3543-76)  / 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0591-3543-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079094","Actavis Pharma, Inc.","0591-3543","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/11/2009","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3543-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0615-8504-39","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8504","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/15/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8504-39)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0615-8504-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8504","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/16/2024","N/A","ANDA","15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8504-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0615-8505-39","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8505","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/15/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8505-39)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0615-8505-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8505","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/12/2024","N/A","ANDA","15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8505-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","0615-8581-39","75 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8581","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2025","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8581-39)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","0615-8582-39","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8582","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2025","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8582-39)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","0615-8601-39","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8601","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/31/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8601-39)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","0615-8602-39","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","NCS HealthCare of KY, LLC dba Vangard Labs","0615-8602","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/04/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8602-39)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0904-6635-61","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Major Pharmaceuticals","0904-6635","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","100 BLISTER PACK in 1 CARTON (0904-6635-61)  / 1 TABLET, FILM COATED in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0904-6636-61","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Major Pharmaceuticals","0904-6636","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","100 BLISTER PACK in 1 CARTON (0904-6636-61)  / 1 TABLET, FILM COATED in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","0904-7099-61","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Major Pharmaceuticals","0904-7099","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/21/2026","N/A","ANDA","100 BLISTER PACK in 1 CARTON (0904-7099-61)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"bupropion hydrochloride","0904-7465-61","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Major Pharmaceuticals","0904-7465","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/15/2024","N/A","ANDA","100 BLISTER PACK in 1 CARTON (0904-7465-61)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","0904-7469-04","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Major Pharmaceuticals","0904-7469","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/07/2024","N/A","ANDA","30 BLISTER PACK in 1 CARTON (0904-7469-04)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0904-7505-61","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Major Pharmaceuticals","0904-7505","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/25/2024","N/A","ANDA","100 BLISTER PACK in 1 CARTON (0904-7505-61)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0904-7505-04","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Major Pharmaceuticals","0904-7505","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/25/2024","N/A","ANDA","30 BLISTER PACK in 1 CARTON (0904-7505-04)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0904-7529-60","75 mg/1","TABLET","ORAL","ANDA206975","MAJOR PHARMACEUTICALS","0904-7529","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/30/2025","N/A","ANDA","100 TABLET in 1 BOTTLE (0904-7529-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","0904-7530-60","100 mg/1","TABLET","ORAL","ANDA206975","MAJOR PHARMACEUTICALS","0904-7530","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/30/2025","N/A","ANDA","100 TABLET in 1 BOTTLE (0904-7530-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-862-10","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-862","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-862-09","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-862","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-862-12","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-862","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-12)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-862-50","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-862","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-50)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-862-03","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-862","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-863-50","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-863","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-50)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-863-09","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-863","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-863-03","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-863","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","16571-863-10","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Rising Pharma Holdings, Inc.","16571-863","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2022","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","16729-443-10","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Accord Healthcare Inc.","16729-443","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/08/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-443-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","16729-443-16","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Accord Healthcare Inc.","16729-443","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/08/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-443-16)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","16729-443-15","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Accord Healthcare Inc.","16729-443","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/08/2018","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-443-15)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","16729-444-16","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Accord Healthcare Inc.","16729-444","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/25/2019","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-444-16)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","16729-444-10","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Accord Healthcare Inc.","16729-444","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/25/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-444-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","23155-191-10","75 mg/1","TABLET","ORAL","ANDA206975","Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.","23155-191","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/19/2016","N/A","ANDA","1000 TABLET in 1 BOTTLE (23155-191-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","23155-191-01","75 mg/1","TABLET","ORAL","ANDA206975","Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.","23155-191","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/19/2016","N/A","ANDA","100 TABLET in 1 BOTTLE (23155-191-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","23155-192-10","100 mg/1","TABLET","ORAL","ANDA206975","Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.","23155-192","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/19/2016","N/A","ANDA","1000 TABLET in 1 BOTTLE (23155-192-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","23155-192-01","100 mg/1","TABLET","ORAL","ANDA206975","Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.","23155-192","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/19/2016","N/A","ANDA","100 TABLET in 1 BOTTLE (23155-192-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","24689-119-01","75 mg/1","TABLET, FILM COATED","ORAL","ANDA075584","Apnar Pharma LP","24689-119","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/20/2021","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (24689-119-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","24689-120-01","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075584","Apnar Pharma LP","24689-120","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/20/2021","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (24689-120-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","24979-101-07","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","TWi Pharmaceuticals, Inc.","24979-101","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/30/2018","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-101-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","24979-101-06","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","TWi Pharmaceuticals, Inc.","24979-101","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/30/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-101-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","24979-101-02","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","TWi Pharmaceuticals, Inc.","24979-101","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/30/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-101-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","24979-102-07","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","TWi Pharmaceuticals, Inc.","24979-102","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/30/2018","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","24979-102-06","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","TWi Pharmaceuticals, Inc.","24979-102","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/30/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","24979-102-02","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","TWi Pharmaceuticals, Inc.","24979-102","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/30/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","24979-248-06","450 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","NDA022497","Upsher-Smith Laboratories, LLC","24979-248","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2023","N/A","NDA AUTHORIZED GENERIC","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-248-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-066-05","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-066","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-066-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-066-01","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-066","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-066-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-066-60","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-066","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-066-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-067-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-067","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-067-25","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-067","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","250 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-25)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-067-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-067","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-067-01","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-067","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-067-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-067","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-068-90","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-068","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-068-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-068-60","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-068","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-068-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-068-01","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-068","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-068-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","31722-068-05","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Camber Pharmaceuticals, Inc.","31722-068","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/31/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-068-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","31722-487-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217898","Camber Pharmaceuticals, Inc.","31722-487","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2025","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-487-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","31722-487-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217898","Camber Pharmaceuticals, Inc.","31722-487","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-487-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","31722-487-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217898","Camber Pharmaceuticals, Inc.","31722-487","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-487-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","31722-488-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217898","Camber Pharmaceuticals, Inc.","31722-488","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2025","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-488-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","31722-488-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217898","Camber Pharmaceuticals, Inc.","31722-488","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-488-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","31722-488-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA217898","Camber Pharmaceuticals, Inc.","31722-488","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-488-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","42571-241-01","75 mg/1","TABLET, FILM COATED","ORAL","ANDA207403","Micro Labs Limited","42571-241","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2020","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (42571-241-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42571-242-01","100 mg/1","TABLET, FILM COATED","ORAL","ANDA207403","Micro Labs Limited","42571-242","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2020","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (42571-242-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-348-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Epic Pharma, LLC","42806-348","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/29/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-348-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-348-09","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Epic Pharma, LLC","42806-348","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-348-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-348-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Epic Pharma, LLC","42806-348","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-348-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-349-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Epic Pharma, LLC","42806-349","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-349-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-349-09","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Epic Pharma, LLC","42806-349","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-349-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42806-410-01","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","Epic Pharma LLC","42806-410","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2021","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-410-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42806-410-05","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","Epic Pharma LLC","42806-410","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2021","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-410-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42806-410-60","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","Epic Pharma LLC","42806-410","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-410-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42806-411-60","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","Epic Pharma LLC","42806-411","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-411-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-413-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA216766","Epic Pharma, LLC","42806-413","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/28/2023","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42806-413-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-414-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Epic Pharma, LLC","42806-414","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/30/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-414-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-414-09","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Epic Pharma, LLC","42806-414","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/30/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-414-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-414-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Epic Pharma, LLC","42806-414","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/30/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-414-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42806-415-01","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","Epic Pharma LLC","42806-415","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2021","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-415-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42806-415-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","Epic Pharma LLC","42806-415","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2021","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-415-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42806-415-52","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","Epic Pharma LLC","42806-415","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2021","N/A","ANDA","250 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-415-52)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","42806-415-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","Epic Pharma LLC","42806-415","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-415-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-416-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Epic Pharma, LLC","42806-416","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/30/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-416-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-416-09","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Epic Pharma, LLC","42806-416","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/30/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-416-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-416-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Epic Pharma, LLC","42806-416","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/30/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-416-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-424-01","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-424","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-424-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-424-05","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-424","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-424-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-424-60","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-424","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-424-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-425-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-425","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-425-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-425-52","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-425","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","250 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-425-52)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-425-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-425","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-425-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-425-01","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-425","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-425-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-426-60","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-426","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-426-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-426-05","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-426","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-426-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","42806-426-01","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Epic Pharma, LLC","42806-426","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-426-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","43063-744-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","PD-Rx Pharmaceuticals, Inc.","43063-744","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/09/2017","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-744-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43063-880-30","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","PD-Rx Pharmaceuticals, Inc.","43063-880","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/13/2018","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-880-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43063-880-60","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","PD-Rx Pharmaceuticals, Inc.","43063-880","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/30/2018","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-880-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43063-913-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","PD-Rx Pharmaceuticals, Inc.","43063-913","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/13/2018","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-913-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","43063-994-30","100 mg/1","TABLET","ORAL","ANDA206975","PD-Rx Pharmaceuticals, Inc.","43063-994","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/20/2019","N/A","ANDA","30 TABLET in 1 BOTTLE, PLASTIC (43063-994-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-288-50","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-288","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-288-50)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-288-10","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-288","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-288-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-288-06","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-288","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-288-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-288-09","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-288","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-288-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-289-09","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-289","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-289-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-289-25","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-289","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-289-25)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-289-50","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-289","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-289-50)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-289-10","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-289","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-289-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-289-06","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-289","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-289-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-290-06","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-290","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-290-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-290-10","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-290","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-290-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-290-50","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-290","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-290-50)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","43547-290-09","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Solco Healthcare US LLC","43547-290","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2014","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43547-290-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-536-01","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-536","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2016","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-536-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-536-05","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-536","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2016","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-536-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-536-60","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-536","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2016","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-536-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-537-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-537","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2016","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-537-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-537-01","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-537","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2016","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-537-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-537-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-537","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2016","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-537-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-538-60","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-538","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/01/2016","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-538-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-655-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Dr Reddys Laboratories Inc","43598-655","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-655-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-655-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Dr Reddys Laboratories Inc","43598-655","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-655-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-655-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Dr Reddys Laboratories Inc","43598-655","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-655-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-656-05","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Dr Reddys Laboratories Inc","43598-656","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-656-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-656-90","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Dr Reddys Laboratories Inc","43598-656","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-656-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-656-30","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Dr Reddys Laboratories Inc","43598-656","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-656-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","43598-751-01","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-751","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/15/2018","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-751-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","43598-751-60","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-751","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/15/2018","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-751-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","43598-751-05","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-751","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/15/2018","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-751-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","43598-752-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-752","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/15/2018","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-752-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","43598-752-01","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-752","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/15/2018","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-752-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","43598-752-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-752","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/15/2018","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-752-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","43598-753-60","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Dr. Reddy’s Laboratories Inc.","43598-753","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/15/2018","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-753-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","45963-142-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Actavis Pharma, Inc.","45963-142","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/15/2015","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","45963-142-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Actavis Pharma, Inc.","45963-142","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/19/2015","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","45963-142-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Actavis Pharma, Inc.","45963-142","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/17/2015","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","46708-118-91","75 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","Alembic Pharmaceuticals Limited","46708-118","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/18/2018","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (46708-118-91)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","46708-118-31","75 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","Alembic Pharmaceuticals Limited","46708-118","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/18/2018","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (46708-118-31)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","46708-127-71","100 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","Alembic Pharmaceuticals Limited","46708-127","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/18/2018","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (46708-127-71)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","46708-127-31","100 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","Alembic Pharmaceuticals Limited","46708-127","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/18/2018","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (46708-127-31)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-736-08","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-736","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-736-08)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-736-86","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-736","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-736-86)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-736-88","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-736","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-736-88)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-736-13","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-736","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-736-13)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-737-08","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-737","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-737-08)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-737-13","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-737","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-737-13)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-737-86","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-737","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-737-86)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-737-88","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-737","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-737-88)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-738-08","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-738","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-738-08)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-738-13","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-738","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-738-13)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-738-86","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-738","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-738-86)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","47335-738-88","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Sun Pharmaceutical Industries, Inc.","47335-738","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/01/2020","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-738-88)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","47335-954-13","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200695","Sun Pharmaceutical Industries, Inc.","47335-954","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/25/2014","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-13)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","47335-954-81","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200695","Sun Pharmaceutical Industries, Inc.","47335-954","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/25/2014","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-81)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","47335-954-83","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200695","Sun Pharmaceutical Industries, Inc.","47335-954","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/25/2014","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-83)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","47781-637-30","450 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","NDA022497","Alvogen Inc.","47781-637","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/28/2018","03/01/2026","NDA AUTHORIZED GENERIC","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-637-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","N/A"
"Bupropion Hydrochloride","50090-1150-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079094","A-S Medication Solutions","50090-1150","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/28/2014","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-1150-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-1150-0","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079094","A-S Medication Solutions","50090-1150","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/28/2014","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50090-1150-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-1869-3","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","A-S Medication Solutions","50090-1869","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/10/2015","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (50090-1869-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-1869-0","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","A-S Medication Solutions","50090-1869","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/10/2015","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (50090-1869-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-4049-2","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","A-S Medication Solutions","50090-4049","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/11/2019","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-4049-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-4049-0","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","A-S Medication Solutions","50090-4049","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/11/2019","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-4049-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-4049-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","A-S Medication Solutions","50090-4049","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/11/2019","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-4049-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-4747-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","A-S Medication Solutions","50090-4747","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/22/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4747-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50090-4747-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","A-S Medication Solutions","50090-4747","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/22/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4747-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50090-4747-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","A-S Medication Solutions","50090-4747","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/22/2019","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4747-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50090-4749-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","A-S Medication Solutions","50090-4749","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/22/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4749-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-4749-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","A-S Medication Solutions","50090-4749","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/22/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4749-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-5163-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","A-S Medication Solutions","50090-5163","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-5163-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","A-S Medication Solutions","50090-5163","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-5163-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","A-S Medication Solutions","50090-5163","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-5245-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","A-S Medication Solutions","50090-5245","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/12/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5245-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-5245-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","A-S Medication Solutions","50090-5245","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/12/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5245-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-5334-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","A-S Medication Solutions","50090-5334","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/03/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5334-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-5334-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","A-S Medication Solutions","50090-5334","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/03/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5334-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-6353-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","A-S Medication Solutions","50090-6353","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6353-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-6353-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","A-S Medication Solutions","50090-6353","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6353-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-6353-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","A-S Medication Solutions","50090-6353","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6353-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-6353-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA075932","A-S Medication Solutions","50090-6353","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6353-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-6789-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","A-S Medication Solutions","50090-6789","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/31/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6789-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50090-6871-0","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","A-S Medication Solutions","50090-6871","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/04/2023","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-6871-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-6871-3","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","A-S Medication Solutions","50090-6871","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/04/2023","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-6871-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-6871-2","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","A-S Medication Solutions","50090-6871","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/04/2023","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-6871-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-6871-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","A-S Medication Solutions","50090-6871","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/04/2023","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-6871-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-6872-0","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","A-S Medication Solutions","50090-6872","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/04/2023","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-6872-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-6961-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","A-S Medication Solutions","50090-6961","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/19/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6961-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-6961-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","A-S Medication Solutions","50090-6961","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/19/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6961-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-6962-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","A-S Medication Solutions","50090-6962","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/19/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6962-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7109-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","A-S Medication Solutions","50090-7109","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50090-7109-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7110-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","A-S Medication Solutions","50090-7110","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7110-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7110-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","A-S Medication Solutions","50090-7110","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7110-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7110-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","A-S Medication Solutions","50090-7110","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7110-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7112-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","A-S Medication Solutions","50090-7112","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50090-7112-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7113-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","A-S Medication Solutions","50090-7113","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7113-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","A-S Medication Solutions","50090-7113","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7113-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","A-S Medication Solutions","50090-7113","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7130-0","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","A-S Medication Solutions","50090-7130","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2024","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7130-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7322-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA216766","A-S Medication Solutions","50090-7322","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2024","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7322-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7322-0","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA216766","A-S Medication Solutions","50090-7322","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2024","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7322-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7334-1","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","A-S Medication Solutions","50090-7334","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2024","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7334-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7334-0","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","A-S Medication Solutions","50090-7334","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2024","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7334-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7335-0","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","A-S Medication Solutions","50090-7335","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2024","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7335-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","50090-7349-0","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","A-S Medication Solutions","50090-7349","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/16/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7349-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","50090-7422-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","A-S Medication Solutions","50090-7422","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","50090-7422-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","A-S Medication Solutions","50090-7422","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","50090-7422-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","A-S Medication Solutions","50090-7422","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2024","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","50090-7422-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","A-S Medication Solutions","50090-7422","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","50090-7423-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","A-S Medication Solutions","50090-7423","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7423-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-7511-3","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","A-S Medication Solutions","50090-7511","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/20/2025","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (50090-7511-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","50090-7511-0","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","A-S Medication Solutions","50090-7511","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/20/2025","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (50090-7511-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7602-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","A-S Medication Solutions","50090-7602","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/14/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7602-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7711-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","A-S Medication Solutions","50090-7711","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/14/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7711-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7711-0","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","A-S Medication Solutions","50090-7711","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/14/2025","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7711-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7711-2","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","A-S Medication Solutions","50090-7711","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/14/2025","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7711-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50090-7712-0","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","A-S Medication Solutions","50090-7712","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/14/2025","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7712-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50228-144-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","ScieGen Pharmaceuticals,Inc.","50228-144","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-144-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-144-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","ScieGen Pharmaceuticals,Inc.","50228-144","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-144-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-144-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","ScieGen Pharmaceuticals,Inc.","50228-144","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-144-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-145-30","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","ScieGen Pharmaceuticals,Inc.","50228-145","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-145-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-145-05","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","ScieGen Pharmaceuticals,Inc.","50228-145","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-145-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-145-90","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","ScieGen Pharmaceuticals,Inc.","50228-145","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-145-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-174-10","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-174","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-174-60","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-174","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-174-30","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-174","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-174-05","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-174","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-174-01","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-174","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-175-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-175","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-175-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-175-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-175","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-175-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-175-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-175","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-175-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-175-10","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-175","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-175-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-175-01","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-175","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-175-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-176-30","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-176","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-176-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-176-01","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-176","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-176-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-176-60","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-176","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-176-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-176-10","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","ScieGen Pharmaceuticals, Inc.","50228-176","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-176-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50228-338-11","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA206122","ScieGen Pharmaceuticals, Inc.","50228-338","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2019","N/A","ANDA","1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-338-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50228-338-61","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA206122","ScieGen Pharmaceuticals, Inc.","50228-338","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2019","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-338-61)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50228-338-31","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA206122","ScieGen Pharmaceuticals, Inc.","50228-338","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2019","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-338-31)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50268-133-13","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","AvPAK","50268-133","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/05/2025","N/A","ANDA","30 BLISTER PACK in 1 BOX (50268-133-13)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-133-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50268-134-13","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","AvPAK","50268-134","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/05/2025","N/A","ANDA","30 BLISTER PACK in 1 BOX (50268-134-13)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-134-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","50268-142-15","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","AvPAK","50268-142","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2017","N/A","ANDA","50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-142-15)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-142-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","50268-143-15","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","AvPAK","50268-143","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/02/2017","N/A","ANDA","50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-143-15)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-143-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","51407-206-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Golden State Medical Supply, Inc.","51407-206","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","51407-206-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Golden State Medical Supply, Inc.","51407-206","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","51407-206-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Golden State Medical Supply, Inc.","51407-206","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2019","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","51407-207-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Golden State Medical Supply, Inc.","51407-207","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-207-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","51407-207-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Golden State Medical Supply, Inc.","51407-207","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-207-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","51655-115-83","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Northwind Health Company, LLC","51655-115","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/05/2023","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-83)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","51655-115-52","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Northwind Health Company, LLC","51655-115","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/30/2022","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-52)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","51655-115-26","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Northwind Health Company, LLC","51655-115","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/15/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-26)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","51655-115-25","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Northwind Health Company, LLC","51655-115","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/05/2022","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-25)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"bupropion Hydrochloride","51655-390-25","100 mg/1","TABLET","ORAL","ANDA206975","Northwind Health Company, LLC","51655-390","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/28/2022","N/A","ANDA","60 TABLET in 1 BOTTLE, PLASTIC (51655-390-25)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"bupropion Hydrochloride","51655-390-26","100 mg/1","TABLET","ORAL","ANDA206975","Northwind Health Company, LLC","51655-390","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/28/2022","N/A","ANDA","90 TABLET in 1 BOTTLE, PLASTIC (51655-390-26)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"bupropion hydrochloride","55154-0183-0","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA202304","Cardinal Health 107, LLC","55154-0183","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/09/2025","N/A","ANDA","10 BLISTER PACK in 1 BAG (55154-0183-0)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","55154-4152-0","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Cardinal Health 107, LLC","55154-4152","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/18/2022","N/A","ANDA","10 BLISTER PACK in 1 BAG (55154-4152-0)  / 1 TABLET, FILM COATED in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","55154-8180-0","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Cardinal Health 107, LLC","55154-8180","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/29/2018","N/A","ANDA","10 BLISTER PACK in 1 BAG (55154-8180-0)  / 1 TABLET, FILM COATED in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","55700-820-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Quality Care Products, LLC","55700-820","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/12/2020","03/31/2026","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-820-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","N/A"
"BUPROPION HYDROCHLORIDE","55700-820-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Quality Care Products, LLC","55700-820","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/22/2019","08/31/2026","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-820-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","N/A"
"BUPROPION HYDROCHLORIDE","55700-849-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Quality Care Products, LLC","55700-849","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/16/2020","02/28/2026","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-849-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","N/A"
"BUPROPION HYDROCHLORIDE","59651-846-05","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA090325","Aurobindo Pharma Limited","59651-846","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-846-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","59651-846-01","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA090325","Aurobindo Pharma Limited","59651-846","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-846-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","59651-847-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA090325","Aurobindo Pharma Limited","59651-847","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-847-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","59651-847-01","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA090325","Aurobindo Pharma Limited","59651-847","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-847-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","59651-848-60","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA090325","Aurobindo Pharma Limited","59651-848","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-848-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","59651-848-01","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA090325","Aurobindo Pharma Limited","59651-848","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-848-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","59651-874-01","75 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Aurobindo Pharma Limited","59651-874","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/25/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (59651-874-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","59651-875-01","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Aurobindo Pharma Limited","59651-875","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/25/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (59651-875-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60429-746-01","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Golden State Medical Supply, Inc.","60429-746","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/22/2019","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (60429-746-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60429-747-01","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Golden State Medical Supply, Inc.","60429-747","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/22/2019","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (60429-747-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0157-7","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0157","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (60505-0157-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0157-5","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0157","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (60505-0157-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0157-3","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0157","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (60505-0157-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0157-9","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0157","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (60505-0157-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0157-1","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0157","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (60505-0157-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0158-9","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0158","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (60505-0158-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0158-1","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0158","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (60505-0158-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0158-3","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0158","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (60505-0158-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0158-7","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0158","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (60505-0158-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60505-0158-5","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Apotex Corp","60505-0158","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (60505-0158-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60687-340-01","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","American Health Packaging","60687-340","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2018","N/A","ANDA","100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-340-01)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-340-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60687-351-01","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","American Health Packaging","60687-351","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2018","N/A","ANDA","100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-351-01)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-351-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60687-782-01","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","American Health Packaging","60687-782","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/15/2024","N/A","ANDA","100 BLISTER PACK in 1 CARTON (60687-782-01)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-782-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60687-793-21","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","American Health Packaging","60687-793","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/15/2024","N/A","ANDA","30 BLISTER PACK in 1 CARTON (60687-793-21)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-793-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","60760-781-30","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","ST. MARY'S MEDICAL PARK PHARMACY","60760-781","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/21/2025","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-781-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","62135-723-90","75 mg/1","TABLET","ORAL","ANDA206975","Chartwell RX, LLC","62135-723","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/11/2023","N/A","ANDA","90 TABLET in 1 BOTTLE (62135-723-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","62135-724-90","100 mg/1","TABLET","ORAL","ANDA206975","Chartwell RX, LLC","62135-724","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/11/2023","N/A","ANDA","90 TABLET in 1 BOTTLE (62135-724-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","62332-118-91","75 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","Alembic Pharmaceuticals Inc.","62332-118","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/10/2024","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (62332-118-91)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","62332-118-31","75 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","Alembic Pharmaceuticals Inc.","62332-118","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/10/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (62332-118-31)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","62332-127-71","100 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","Alembic Pharmaceuticals Inc.","62332-127","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/10/2024","N/A","ANDA","500 TABLET, FILM COATED in 1 BOTTLE (62332-127-71)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","62332-127-31","100 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","Alembic Pharmaceuticals Inc.","62332-127","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/10/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (62332-127-31)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-052-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-052","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-052-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-052-78","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-052","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-052-78)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-052-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-052","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-052-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-176-78","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-176","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-176-78)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-176-60","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-176","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-176-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-176-30","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-176","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-176-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-178-90","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-178","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-178-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-178-30","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-178","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-178-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63187-178-60","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA078866","Proficient Rx LP","63187-178","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/01/2014","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-178-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-566-30","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-566","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-566-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-566-60","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-566","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-566-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-566-90","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-566","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-566-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-713-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077415","Proficient Rx LP","63187-713","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/01/2016","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-713-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-713-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077415","Proficient Rx LP","63187-713","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/01/2016","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-713-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-713-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077415","Proficient Rx LP","63187-713","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/01/2016","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63187-713-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-726-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-726","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2016","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-726-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-726","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2016","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-726-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-726","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2016","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-766-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Proficient Rx LP","63187-766","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2016","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-766-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-766-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Proficient Rx LP","63187-766","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2016","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-766-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-766-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Proficient Rx LP","63187-766","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2016","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-766-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-819-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Proficient Rx LP","63187-819","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2017","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-819-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-819-78","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Proficient Rx LP","63187-819","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2017","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-819-78)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-819-60","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Proficient Rx LP","63187-819","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2017","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-819-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-819-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Proficient Rx LP","63187-819","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2017","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-819-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-952-14","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-952","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/07/2024","N/A","ANDA","14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-952-14)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-952-30","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-952","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2018","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-952-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-952-60","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-952","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2018","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-952-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63187-952-90","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Proficient Rx LP","63187-952","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2018","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-952-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63304-723-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200216","Sun Pharmaceutical Industries, Inc.","63304-723","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/09/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63304-723-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200216","Sun Pharmaceutical Industries, Inc.","63304-723","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/09/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63304-723-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA200216","Sun Pharmaceutical Industries, Inc.","63304-723","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/09/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63304-724-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203650","Sun Pharmaceutical Industries, Inc.","63304-724","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2021","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-724-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63304-724-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203650","Sun Pharmaceutical Industries, Inc.","63304-724","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2021","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-724-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","63304-724-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA203650","Sun Pharmaceutical Industries, Inc.","63304-724","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2021","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-724-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63629-2138-1","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077284","Bryant Ranch Prepack","63629-2138","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/12/2007","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-2138-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63629-8473-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","63629-8473","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-8473-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63629-8474-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","63629-8474","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-8474-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63629-8475-1","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","63629-8475","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-8475-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","63629-8476-1","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","63629-8476","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/12/2017","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-8476-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","67046-1497-3","300 mg/1","TABLET","ORAL","ANDA215568","Coupler LLC","67046-1497","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/28/2025","N/A","ANDA","30 TABLET in 1 BLISTER PACK (67046-1497-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","67046-1562-3","100 mg/1","TABLET","ORAL","ANDA206975","Coupler LLC","67046-1562","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/21/2025","N/A","ANDA","30 TABLET in 1 BLISTER PACK (67046-1562-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","67046-1572-3","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Coupler LLC","67046-1572","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/02/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (67046-1572-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","67046-1587-3","75 mg/1","TABLET","ORAL","ANDA206975","Coupler LLC","67046-1587","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2025","N/A","ANDA","30 TABLET in 1 BLISTER PACK (67046-1587-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","67046-1641-3","75 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Coupler LLC","67046-1641","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/06/2026","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (67046-1641-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","67046-1648-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Coupler LLC","67046-1648","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/15/2026","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (67046-1648-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","68001-308-00","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","BluePoint Laboratories","68001-308","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/08/2017","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (68001-308-00)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68001-309-00","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","BluePoint Laboratories","68001-309","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/08/2017","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (68001-309-00)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68001-519-03","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","BluePoint Laboratories","68001-519","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/13/2021","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68001-519-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","BluePoint Laboratories","68001-519","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/13/2021","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68001-519-04","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","BluePoint Laboratories","68001-519","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/13/2021","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-04)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68001-520-04","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","BluePoint Laboratories","68001-520","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/13/2021","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-520-04)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68001-520-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","BluePoint Laboratories","68001-520","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/13/2021","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-520-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68001-520-03","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","BluePoint Laboratories","68001-520","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/13/2021","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-520-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68001-613-03","150 mg/1","TABLET","ORAL","ANDA215568","BluePoint Laboratories","68001-613","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/08/2024","N/A","ANDA","500 TABLET in 1 BOTTLE (68001-613-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68001-613-04","150 mg/1","TABLET","ORAL","ANDA215568","BluePoint Laboratories","68001-613","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/25/2024","N/A","ANDA","30 TABLET in 1 BOTTLE (68001-613-04)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68001-613-05","150 mg/1","TABLET","ORAL","ANDA215568","BluePoint Laboratories","68001-613","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/24/2024","N/A","ANDA","90 TABLET in 1 BOTTLE (68001-613-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68001-614-03","300 mg/1","TABLET","ORAL","ANDA215568","BluePoint Laboratories","68001-614","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/09/2024","N/A","ANDA","500 TABLET in 1 BOTTLE (68001-614-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68001-614-04","300 mg/1","TABLET","ORAL","ANDA215568","BluePoint Laboratories","68001-614","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/20/2024","N/A","ANDA","30 TABLET in 1 BOTTLE (68001-614-04)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68001-614-05","300 mg/1","TABLET","ORAL","ANDA215568","BluePoint Laboratories","68001-614","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/20/2024","N/A","ANDA","90 TABLET in 1 BOTTLE (68001-614-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","68071-2256-1","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","NuCare Pharmaceuticals,Inc.","68071-2256","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/10/2020","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (68071-2256-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-2577-9","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","NuCare Pharmaceuticals,Inc.","68071-2577","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/23/2025","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (68071-2577-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-2577-3","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","NuCare Pharmaceuticals,Inc.","68071-2577","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/17/2021","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (68071-2577-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-2890-3","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","NuCare Pharmaceuticals,Inc.","68071-2890","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/30/2022","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-2890-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-2890-6","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","NuCare Pharmaceuticals,Inc.","68071-2890","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/26/2025","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-2890-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-3559-9","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","NuCare Pharmaceuticals,Inc.","68071-3559","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/09/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-3559-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-3594-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","NuCare Pharmacueticals, Inc.","68071-3594","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/09/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-3594-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-3927-3","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","NuCare Pharmaceuticals, Inc.","68071-3927","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/10/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68071-3927-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-3928-9","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","NuCare Pharmaceuticals,Inc.","68071-3928","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/08/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-3928-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68071-3932-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","NuCare Pharmaceuticals, Inc.","68071-3932","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/09/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-3932-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BuPROPion Hydrochloride","68084-697-01","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","American Health Packaging","68084-697","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/02/2015","N/A","ANDA","100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-697-01)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (68084-697-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BuPROPion Hydrochloride","68084-708-25","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","American Health Packaging","68084-708","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/01/2015","N/A","ANDA","30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-708-25)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (68084-708-95)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68180-319-06","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Lupin Pharmaceuticals, Inc.","68180-319","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/2017","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-319-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68180-319-02","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Lupin Pharmaceuticals, Inc.","68180-319","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/2017","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-319-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68180-319-09","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Lupin Pharmaceuticals, Inc.","68180-319","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/2017","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-319-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68180-320-02","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Lupin Pharmaceuticals, Inc.","68180-320","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/2017","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-320-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68180-320-06","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Lupin Pharmaceuticals, Inc.","68180-320","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/2017","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-320-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68180-320-09","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Lupin Pharmaceuticals, Inc.","68180-320","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/14/2017","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-320-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-4010-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-4010","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/04/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-4010-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-4010-9","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-4010","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/04/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-4010-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-4010-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-4010","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/04/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-4010-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-4010-6","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-4010","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/04/2025","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-4010-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7786-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7786","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/21/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7786-6","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7786","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/21/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7786-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7786","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/21/2020","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7786-9","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7786","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/21/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7786-8","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7786","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/21/2020","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7793-1","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7793","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/13/2020","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7793-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7793-9","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7793","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/13/2020","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7793-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7793-8","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7793","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/13/2020","N/A","ANDA","120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7793-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7793-6","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7793","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/13/2020","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7793-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7793-3","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7793","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/13/2020","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7793-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7793-2","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7793","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/13/2020","N/A","ANDA","20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7793-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7807-6","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7807","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2020","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7807-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7807-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7807","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2020","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7807-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7807-2","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7807","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2020","N/A","ANDA","20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7807-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7807-8","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7807","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2020","N/A","ANDA","120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7807-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7807-9","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7807","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2020","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7807-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7807-3","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7807","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/28/2020","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7807-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7819-9","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7819","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/13/2020","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7819-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7819-3","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7819","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/13/2020","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7819-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7819-6","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Preferred Pharmaceuticals, Inc.","68788-7819","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/13/2020","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7819-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7988-3","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Preferred Pharmaceuticals Inc.","68788-7988","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/06/2021","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (68788-7988-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7988-9","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Preferred Pharmaceuticals Inc.","68788-7988","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/06/2021","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (68788-7988-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7988-6","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Preferred Pharmaceuticals Inc.","68788-7988","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/06/2021","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (68788-7988-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-7988-1","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Preferred Pharmaceuticals Inc.","68788-7988","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/11/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (68788-7988-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7992-8","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7992","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/06/2021","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7992-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7992","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/06/2021","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7992-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7992","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/06/2021","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7992-9","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7992","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/06/2021","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","68788-7992-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Preferred Pharmaceuticals Inc.","68788-7992","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/06/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7992-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8537-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Preferred Pharmaceuticals Inc.","68788-8537","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/19/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8537-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Preferred Pharmaceuticals Inc.","68788-8537","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/19/2023","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8537-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Preferred Pharmaceuticals Inc.","68788-8537","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/19/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8537-8","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Preferred Pharmaceuticals Inc.","68788-8537","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/19/2023","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8537-9","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Preferred Pharmaceuticals Inc.","68788-8537","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/19/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8589-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Preferred Pharmaceuticals Inc.","68788-8589","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/20/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8589-8","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Preferred Pharmaceuticals Inc.","68788-8589","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/20/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8589-9","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Preferred Pharmaceuticals Inc.","68788-8589","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/20/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8589-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Preferred Pharmaceuticals Inc.","68788-8589","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/20/2024","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8589-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","Preferred Pharmaceuticals Inc.","68788-8589","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/20/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8677-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Preferred Pharmaceuticals, Inc.","68788-8677","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/23/2024","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8677-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Preferred Pharmaceuticals, Inc.","68788-8677","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/23/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8677-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Preferred Pharmaceuticals, Inc.","68788-8677","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/23/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8677-8","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Preferred Pharmaceuticals, Inc.","68788-8677","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/23/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","68788-8677-9","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Preferred Pharmaceuticals, Inc.","68788-8677","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/23/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8677-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-8769-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Preferred Pharmaceuticals Inc.","68788-8769","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/19/2024","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68788-8769-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Preferred Pharmaceuticals Inc.","68788-8769","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/19/2024","N/A","ANDA","20 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68788-8769-6","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Preferred Pharmaceuticals Inc.","68788-8769","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/19/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68788-8769-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Preferred Pharmaceuticals Inc.","68788-8769","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/19/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68788-8769-8","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Preferred Pharmaceuticals Inc.","68788-8769","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/19/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68788-8769-9","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Preferred Pharmaceuticals Inc.","68788-8769","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/19/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8769-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","68788-8815-9","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-8815","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/21/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8815-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-8815-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-8815","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/21/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8815-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-8815-8","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-8815","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/21/2025","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8815-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-8815-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-8815","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/21/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8815-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","68788-8815-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Preferred Pharmaceuticals Inc.","68788-8815","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/21/2025","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8815-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69097-071-12","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Cipla USA., Inc.","69097-071","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/25/2023","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-071-12)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69097-072-12","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Cipla USA., Inc.","69097-072","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/25/2023","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-072-12)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69097-875-02","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","CIPLA USA INC.,","69097-875","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2016","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69097-875-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","CIPLA USA INC.,","69097-875","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2016","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69097-875-12","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","CIPLA USA INC.,","69097-875","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2016","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-12)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69097-876-02","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","CIPLA USA INC.,","69097-876","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2016","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-876-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69097-876-12","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","CIPLA USA INC.,","69097-876","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2016","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-876-12)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","69097-917-07","75 mg/1","TABLET","ORAL","ANDA207389","CIPLA USA INC.,","69097-917","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/26/2018","N/A","ANDA","100 TABLET in 1 BOTTLE (69097-917-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","69097-917-02","75 mg/1","TABLET","ORAL","ANDA207389","CIPLA USA INC.,","69097-917","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/26/2018","N/A","ANDA","30 TABLET in 1 BOTTLE (69097-917-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","69097-917-15","75 mg/1","TABLET","ORAL","ANDA207389","CIPLA USA INC.,","69097-917","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/26/2018","N/A","ANDA","1000 TABLET in 1 BOTTLE (69097-917-15)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","69097-918-15","100 mg/1","TABLET","ORAL","ANDA207389","CIPLA USA INC.,","69097-918","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/26/2018","N/A","ANDA","1000 TABLET in 1 BOTTLE (69097-918-15)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","69097-918-02","100 mg/1","TABLET","ORAL","ANDA207389","CIPLA USA INC.,","69097-918","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/26/2018","N/A","ANDA","30 TABLET in 1 BOTTLE (69097-918-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","69097-918-07","100 mg/1","TABLET","ORAL","ANDA207389","CIPLA USA INC.,","69097-918","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/26/2018","N/A","ANDA","100 TABLET in 1 BOTTLE (69097-918-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69367-288-09","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Westminster Pharmaceuticals, LLC","69367-288","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-288-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69367-288-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Westminster Pharmaceuticals, LLC","69367-288","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/29/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-288-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69367-289-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Westminster Pharmaceuticals, LLC","69367-289","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-289-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","69367-289-09","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Westminster Pharmaceuticals, LLC","69367-289","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2017","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-289-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-125-03","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-125","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-125-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-125-06","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-125","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-125-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-125-05","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-125","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-125-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-126-06","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-126","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-126-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-126-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-126","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-126-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-126-03","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-126","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-126-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-127-05","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-127","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-127-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-127-03","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-127","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-127-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70010-127-06","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA218385","Granules Pharmaceuticals Inc.","70010-127","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/31/2025","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70010-127-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70010-784-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Granules Pharmaceuticals Inc.","70010-784","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2022","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-784-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70010-784-09","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Granules Pharmaceuticals Inc.","70010-784","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-784-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70010-784-03","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Granules Pharmaceuticals Inc.","70010-784","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2022","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-784-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70010-785-09","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Granules Pharmaceuticals Inc.","70010-785","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-785-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70010-785-03","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Granules Pharmaceuticals Inc.","70010-785","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2022","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-785-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70010-785-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Granules Pharmaceuticals Inc.","70010-785","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2022","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-785-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-010-06","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Slate Run Pharmaceuticals, LLC","70436-010","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-010-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-010-04","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Slate Run Pharmaceuticals, LLC","70436-010","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-010-04)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-010-02","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Slate Run Pharmaceuticals, LLC","70436-010","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-010-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-011-06","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Slate Run Pharmaceuticals, LLC","70436-011","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-011-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-011-04","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Slate Run Pharmaceuticals, LLC","70436-011","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-011-04)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-011-02","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Slate Run Pharmaceuticals, LLC","70436-011","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/01/2018","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-011-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-058-05","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-058","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-058-02","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-058","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-058-01","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-058","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-059-22","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-059","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","250 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-22)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-059-02","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-059","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-059-01","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-059","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-059-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-059","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-060-05","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-060","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-060-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-060-01","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-060","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-060-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70436-060-02","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Slate Run Pharmaceuticals, LLC","70436-060","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/02/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-060-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-1566-0","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","REMEDYREPACK INC.","70518-1566","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/22/2018","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1566-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","70518-2022-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","REMEDYREPACK INC.","70518-2022","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/06/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2022-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","70518-2458-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","REMEDYREPACK INC.","70518-2458","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/29/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2458-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","70518-2458-7","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","REMEDYREPACK INC.","70518-2458","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/27/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2458-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","70518-2458-6","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","REMEDYREPACK INC.","70518-2458","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/12/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2458-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","70518-2458-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","REMEDYREPACK INC.","70518-2458","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/06/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2458-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","70518-2772-2","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","REMEDYREPACK INC.","70518-2772","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/26/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2772-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","70518-3787-1","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","REMEDYREPACK INC.","70518-3787","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/14/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (70518-3787-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-3790-0","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","REMEDYREPACK INC.","70518-3790","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/13/2023","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (70518-3790-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-3790-1","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","REMEDYREPACK INC.","70518-3790","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/07/2024","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3790-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-3963-3","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","REMEDYREPACK INC.","70518-3963","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/19/2024","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (70518-3963-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-4014-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","REMEDYREPACK INC.","70518-4014","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/07/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4014-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-4014-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","REMEDYREPACK INC.","70518-4014","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/03/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4014-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-4056-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","REMEDYREPACK INC.","70518-4056","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/23/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (70518-4056-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70518-4081-4","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","REMEDYREPACK INC.","70518-4081","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/27/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4081-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70518-4081-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","REMEDYREPACK INC.","70518-4081","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2025","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4081-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70518-4081-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","REMEDYREPACK INC.","70518-4081","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4081-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70518-4081-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","REMEDYREPACK INC.","70518-4081","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/26/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4081-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70518-4093-0","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","REMEDYREPACK INC.","70518-4093","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/04/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4093-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70518-4189-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","REMEDYREPACK INC.","70518-4189","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/26/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4189-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-4218-1","100 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","REMEDYREPACK INC.","70518-4218","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/08/2026","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4218-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","70518-4218-0","100 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","REMEDYREPACK INC.","70518-4218","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/21/2024","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4218-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","70518-4264-0","75 mg/1","TABLET, FILM COATED","ORAL","ANDA203013","REMEDYREPACK INC.","70518-4264","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/24/2025","N/A","ANDA","30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4264-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion hydrochloride","70518-4343-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211020","REMEDYREPACK INC.","70518-4343","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/19/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4343-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70518-4415-0","300 mg/1","TABLET","ORAL","ANDA215568","REMEDYREPACK INC.","70518-4415","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/31/2025","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-4415-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-4446-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","REMEDYREPACK INC.","70518-4446","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/18/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4446-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","70518-4448-0","150 mg/1","TABLET","ORAL","ANDA215568","REMEDYREPACK INC.","70518-4448","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/19/2025","N/A","ANDA","30 TABLET in 1 BLISTER PACK (70518-4448-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","70518-4551-0","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","REMEDYREPACK INC.","70518-4551","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/20/2026","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4551-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","71205-291-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Proficient Rx LP","71205-291","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-291-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-291-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Proficient Rx LP","71205-291","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-291-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-291-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Proficient Rx LP","71205-291","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2019","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-291-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-394-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Proficient Rx LP","71205-394","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/03/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-394-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-394-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Proficient Rx LP","71205-394","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/03/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-394-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-394-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Proficient Rx LP","71205-394","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/03/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-394-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71205-465-60","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Proficient Rx LP","71205-465","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/29/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71205-465-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Proficient Rx LP","71205-465","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/29/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71205-465-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Proficient Rx LP","71205-465","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/29/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71205-504-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Proficient Rx LP","71205-504","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/13/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71205-504-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Proficient Rx LP","71205-504","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/13/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71205-504-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Proficient Rx LP","71205-504","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/13/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-550-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Proficient Rx LP","71205-550","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/01/2021","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-550-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-550-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Proficient Rx LP","71205-550","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/01/2021","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-550-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-550-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Proficient Rx LP","71205-550","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/01/2021","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-550-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-967-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Proficient Rx LP","71205-967","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/09/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-967-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-967-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Proficient Rx LP","71205-967","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/09/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-967-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-967-55","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Proficient Rx LP","71205-967","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/09/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-967-55)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-968-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Proficient Rx LP","71205-968","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/09/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-968-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-968-55","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Proficient Rx LP","71205-968","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/09/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-968-55)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71205-968-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Proficient Rx LP","71205-968","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/09/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-968-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71209-052-05","75 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Cadila Pharmaceuticals Limited","71209-052","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (71209-052-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71209-052-11","75 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Cadila Pharmaceuticals Limited","71209-052","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (71209-052-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71209-052-17","75 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Cadila Pharmaceuticals Limited","71209-052","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","10 BLISTER PACK in 1 CARTON (71209-052-17)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71209-053-17","100 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Cadila Pharmaceuticals Limited","71209-053","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","10 BLISTER PACK in 1 CARTON (71209-053-17)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71209-053-05","100 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Cadila Pharmaceuticals Limited","71209-053","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (71209-053-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71209-053-11","100 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Cadila Pharmaceuticals Limited","71209-053","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (71209-053-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0013-4","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0013","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2024","N/A","ANDA","7 TABLET, FILM COATED in 1 BOTTLE (71335-0013-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0013-6","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0013","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2024","N/A","ANDA","120 TABLET, FILM COATED in 1 BOTTLE (71335-0013-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0013-3","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0013","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2024","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (71335-0013-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0013-1","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0013","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/08/2018","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (71335-0013-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0013-2","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0013","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/21/2018","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (71335-0013-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0013-5","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0013","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2024","N/A","ANDA","14 TABLET, FILM COATED in 1 BOTTLE (71335-0013-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0013-7","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0013","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (71335-0013-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-6","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/08/2024","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-3","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/11/2019","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-7","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/08/2024","N/A","ANDA","28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-5","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/08/2024","N/A","ANDA","45 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-2","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/18/2019","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/11/2019","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-4","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/08/2024","N/A","ANDA","120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-9","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/08/2024","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0135-8","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA079095","Bryant Ranch Prepack","71335-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/08/2024","N/A","ANDA","56 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-0135-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0182-7","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0182","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/28/2021","N/A","ANDA","21 TABLET, FILM COATED in 1 BOTTLE (71335-0182-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0182-6","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0182","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2024","N/A","ANDA","15 TABLET, FILM COATED in 1 BOTTLE (71335-0182-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0182-1","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0182","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/24/2018","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (71335-0182-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0182-4","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0182","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/28/2018","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (71335-0182-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0182-3","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0182","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2024","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (71335-0182-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0182-2","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0182","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/20/2018","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (71335-0182-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-0182-5","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","71335-0182","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/09/2024","N/A","ANDA","120 TABLET, FILM COATED in 1 BOTTLE (71335-0182-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0791-2","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-0791","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/19/2019","N/A","ANDA","60 TABLET in 1 BOTTLE (71335-0791-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0791-6","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-0791","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/19/2019","N/A","ANDA","120 TABLET in 1 BOTTLE (71335-0791-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0791-5","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-0791","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/19/2019","N/A","ANDA","14 TABLET in 1 BOTTLE (71335-0791-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0791-7","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-0791","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/19/2019","N/A","ANDA","100 TABLET in 1 BOTTLE (71335-0791-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0791-4","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-0791","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/19/2019","N/A","ANDA","7 TABLET in 1 BOTTLE (71335-0791-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0791-3","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-0791","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/19/2019","N/A","ANDA","90 TABLET in 1 BOTTLE (71335-0791-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0791-1","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-0791","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/26/2018","N/A","ANDA","30 TABLET in 1 BOTTLE (71335-0791-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0877-7","100 mg/1","TABLET","ORAL","ANDA207389","Bryant Ranch Prepack","71335-0877","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/27/2021","N/A","ANDA","21 TABLET in 1 BOTTLE (71335-0877-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0877-1","100 mg/1","TABLET","ORAL","ANDA207389","Bryant Ranch Prepack","71335-0877","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/07/2018","N/A","ANDA","60 TABLET in 1 BOTTLE (71335-0877-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0877-6","100 mg/1","TABLET","ORAL","ANDA207389","Bryant Ranch Prepack","71335-0877","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/27/2021","N/A","ANDA","15 TABLET in 1 BOTTLE (71335-0877-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0877-5","100 mg/1","TABLET","ORAL","ANDA207389","Bryant Ranch Prepack","71335-0877","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/27/2021","N/A","ANDA","120 TABLET in 1 BOTTLE (71335-0877-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0877-4","100 mg/1","TABLET","ORAL","ANDA207389","Bryant Ranch Prepack","71335-0877","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/13/2018","N/A","ANDA","90 TABLET in 1 BOTTLE (71335-0877-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0877-3","100 mg/1","TABLET","ORAL","ANDA207389","Bryant Ranch Prepack","71335-0877","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/27/2021","N/A","ANDA","100 TABLET in 1 BOTTLE (71335-0877-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-0877-2","100 mg/1","TABLET","ORAL","ANDA207389","Bryant Ranch Prepack","71335-0877","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/21/2018","N/A","ANDA","30 TABLET in 1 BOTTLE (71335-0877-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1044-4","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1044","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/28/2021","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1044-5","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1044","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/28/2021","N/A","ANDA","14 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1044-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1044","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/10/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1044-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1044","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/03/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1044-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1044","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/28/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1114-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Bryant Ranch Prepack","71335-1114","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/05/2024","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1114-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Bryant Ranch Prepack","71335-1114","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/21/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1114-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Bryant Ranch Prepack","71335-1114","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/22/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1114-5","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Bryant Ranch Prepack","71335-1114","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/05/2024","N/A","ANDA","8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1114-2","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Bryant Ranch Prepack","71335-1114","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/05/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1114-4","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Bryant Ranch Prepack","71335-1114","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/29/2019","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1214-4","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1214","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/29/2019","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1214-5","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1214","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/09/2024","N/A","ANDA","8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1214-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1214","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/03/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1214-2","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1214","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/22/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1214-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1214","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/09/2024","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-1214-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Bryant Ranch Prepack","71335-1214","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/10/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1214-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-4","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/04/2024","N/A","ANDA","120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-5","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/04/2024","N/A","ANDA","45 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-2","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/20/2020","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-3","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/06/2020","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-6","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/08/2020","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-8","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/04/2024","N/A","ANDA","56 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-1","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2020","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-7","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/04/2024","N/A","ANDA","28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1702-9","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1702","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/04/2024","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-1702-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-4","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/17/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/05/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-5","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/17/2024","N/A","ANDA","45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/17/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-6","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/02/2022","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-7","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/17/2024","N/A","ANDA","28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/26/2021","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-8","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/17/2024","N/A","ANDA","56 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1837-9","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1837","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/17/2024","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1837-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1866-3","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1866","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2021","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1866-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1866-6","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1866","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/06/2022","N/A","ANDA","120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1866-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1866-1","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1866","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/21/2021","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1866-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1866-2","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1866","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/17/2024","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1866-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1866-5","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1866","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/17/2024","N/A","ANDA","28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1866-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1866-4","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1866","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/17/2024","N/A","ANDA","45 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1866-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1870-4","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1870","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1870-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1870-5","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1870","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1870-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1870-3","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1870","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1870-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1870-1","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1870","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/24/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1870-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1870-2","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1870","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1870-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1870-6","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1870","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1870-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1984-1","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1984","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/27/2022","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1984-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1984-6","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1984","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1984-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1984-3","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1984","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/06/2022","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1984-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1984-2","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1984","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1984-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1984-5","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1984","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1984-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1984-4","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","71335-1984","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1984-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1986-5","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1986","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1986-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1986-1","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1986","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/04/2021","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1986-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1986-2","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1986","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1986-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1986-4","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1986","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1986-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1986-3","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1986","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1986-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-1986-6","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211347","Bryant Ranch Prepack","71335-1986","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/29/2022","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1986-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2312-3","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","71335-2312","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/21/2023","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-2312-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2312-6","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","71335-2312","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/21/2023","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-2312-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2312-2","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","71335-2312","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/21/2023","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-2312-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2312-5","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","71335-2312","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/21/2023","N/A","ANDA","8 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-2312-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2312-1","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","71335-2312","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/21/2023","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-2312-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2312-4","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","71335-2312","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/21/2023","N/A","ANDA","120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-2312-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2378-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Bryant Ranch Prepack","71335-2378","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/12/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2378-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2378-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Bryant Ranch Prepack","71335-2378","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/27/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2378-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2378-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Bryant Ranch Prepack","71335-2378","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/16/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2378-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2378-4","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Bryant Ranch Prepack","71335-2378","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2025","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2378-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71335-2378-5","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Bryant Ranch Prepack","71335-2378","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2025","N/A","ANDA","14 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2378-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2400-6","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2400","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/13/2024","N/A","ANDA","28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2400-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2400-4","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2400","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/13/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2400-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2400-1","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2400","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/13/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2400-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2400-3","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2400","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/13/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2400-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2400-5","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2400","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/13/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2400-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2400-2","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2400","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/13/2024","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2400-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-9","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-5","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-6","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-8","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","56 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-8)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-7","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-4","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2457-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2457","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/20/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2457-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2469-5","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2469","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/12/2024","N/A","ANDA","14 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2469-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2469","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/12/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2469-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2469","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/12/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2469-4","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2469","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/12/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2469-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2469","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/12/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2469-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2496-3","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2496","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2496-2","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2496","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2496-5","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2496","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2024","N/A","ANDA","28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2496-6","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2496","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2496-1","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2496","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2496-4","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2496","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/16/2024","N/A","ANDA","45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2499-4","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2499","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2024","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2499-5","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2499","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2024","N/A","ANDA","8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2499-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2499","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2499-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2499","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2024","N/A","ANDA","180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2499-2","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2499","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2499-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA215568","Bryant Ranch Prepack","71335-2499","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2649-2","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2649","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2649-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2649-4","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2649","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2649-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2649-3","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2649","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2649-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2649-1","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2649","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2649-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2649-5","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2649","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2649-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2649-7","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2649","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","21 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2649-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","71335-2649-6","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA216800","Bryant Ranch Prepack","71335-2649","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","15 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2649-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-2652-6","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Bryant Ranch Prepack","71335-2652","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","15 TABLET, FILM COATED in 1 BOTTLE (71335-2652-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-2652-4","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Bryant Ranch Prepack","71335-2652","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE (71335-2652-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-2652-5","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Bryant Ranch Prepack","71335-2652","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","120 TABLET, FILM COATED in 1 BOTTLE (71335-2652-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-2652-3","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Bryant Ranch Prepack","71335-2652","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (71335-2652-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-2652-1","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Bryant Ranch Prepack","71335-2652","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (71335-2652-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-2652-2","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Bryant Ranch Prepack","71335-2652","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (71335-2652-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","71335-2652-7","100 mg/1","TABLET, FILM COATED","ORAL","ANDA075491","Bryant Ranch Prepack","71335-2652","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/03/2025","N/A","ANDA","21 TABLET, FILM COATED in 1 BOTTLE (71335-2652-7)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-2690-1","100 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-2690","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/30/2025","N/A","ANDA","100 TABLET in 1 BOTTLE (71335-2690-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-2867-1","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-2867","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/22/2025","N/A","ANDA","100 TABLET in 1 BOTTLE (71335-2867-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71335-2875-1","100 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","71335-2875","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/22/2025","N/A","ANDA","100 TABLET in 1 BOTTLE (71335-2875-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-164-83","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Aphena Pharma Solutions - Tennessee, LLC","71610-164","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/26/2018","N/A","ANDA","3600 TABLET, FILM COATED in 1 BOTTLE (71610-164-83)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-576-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Aphena Pharma Solutions - Tennessee, LLC","71610-576","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/11/2021","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-576-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-576-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Aphena Pharma Solutions - Tennessee, LLC","71610-576","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2021","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-576-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-576-80","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Aphena Pharma Solutions - Tennessee, LLC","71610-576","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/01/2021","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-576-80)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-582-83","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Aphena Pharma Solutions - Tennessee, LLC","71610-582","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/15/2021","N/A","ANDA","3600 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-582-83)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-708-80","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Aphena Pharma Solutions - Tennessee, LLC","71610-708","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/16/2023","N/A","ANDA","180 TABLET, FILM COATED in 1 BOTTLE (71610-708-80)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-774-70","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Aphena Pharma Solutions - Tennessee, LLC","71610-774","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/25/2024","N/A","ANDA","120 TABLET, FILM COATED in 1 BOTTLE (71610-774-70)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-774-80","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Aphena Pharma Solutions - Tennessee, LLC","71610-774","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/25/2024","N/A","ANDA","180 TABLET, FILM COATED in 1 BOTTLE (71610-774-80)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-774-53","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Aphena Pharma Solutions - Tennessee, LLC","71610-774","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/22/2024","N/A","ANDA","60 TABLET, FILM COATED in 1 BOTTLE (71610-774-53)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-774-94","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Aphena Pharma Solutions - Tennessee, LLC","71610-774","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/25/2024","N/A","ANDA","360 TABLET, FILM COATED in 1 BOTTLE (71610-774-94)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71610-866-80","75 mg/1","TABLET","ORAL","ANDA206975","Aphena Pharma Solutions - Tennessee, LLC","71610-866","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/21/2024","N/A","ANDA","180 TABLET in 1 BOTTLE (71610-866-80)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71610-866-70","75 mg/1","TABLET","ORAL","ANDA206975","Aphena Pharma Solutions - Tennessee, LLC","71610-866","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/21/2024","N/A","ANDA","120 TABLET in 1 BOTTLE (71610-866-70)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71610-866-60","75 mg/1","TABLET","ORAL","ANDA206975","Aphena Pharma Solutions - Tennessee, LLC","71610-866","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/21/2024","N/A","ANDA","90 TABLET in 1 BOTTLE (71610-866-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","71610-866-53","75 mg/1","TABLET","ORAL","ANDA206975","Aphena Pharma Solutions - Tennessee, LLC","71610-866","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/21/2024","N/A","ANDA","60 TABLET in 1 BOTTLE (71610-866-53)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-899-80","75 mg/1","TABLET","ORAL","ANDA206975","Aphena Pharma Solutions - Tennessee, LLC","71610-899","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","180 TABLET in 1 BOTTLE (71610-899-80)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-899-60","75 mg/1","TABLET","ORAL","ANDA206975","Aphena Pharma Solutions - Tennessee, LLC","71610-899","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","90 TABLET in 1 BOTTLE (71610-899-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","71610-899-53","75 mg/1","TABLET","ORAL","ANDA206975","Aphena Pharma Solutions - Tennessee, LLC","71610-899","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2025","N/A","ANDA","60 TABLET in 1 BOTTLE (71610-899-53)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72162-1278-9","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","Bryant Ranch Prepack","72162-1278","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/01/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1278-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72162-1526-5","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","72162-1526","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/07/2023","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1526-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72162-1526-3","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","72162-1526","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/07/2023","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1526-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72162-1527-5","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","72162-1527","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/23/2024","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1527-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72162-1527-3","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Bryant Ranch Prepack","72162-1527","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/23/2024","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1527-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72162-1529-5","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Bryant Ranch Prepack","72162-1529","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/20/2018","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1529-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72162-2097-1","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","72162-2097","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (72162-2097-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72162-2098-1","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Bryant Ranch Prepack","72162-2098","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/17/2006","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (72162-2098-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","72162-2400-1","75 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","72162-2400","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/02/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (72162-2400-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","72162-2401-1","100 mg/1","TABLET","ORAL","ANDA206975","Bryant Ranch Prepack","72162-2401","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/02/2024","N/A","ANDA","100 TABLET in 1 BOTTLE (72162-2401-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","72189-057-30","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","DIRECT RX","72189-057","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/08/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-057-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","72189-057-60","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA202304","DIRECT RX","72189-057","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/08/2019","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-057-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","72189-124-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","DIRECT RX","72189-124","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/14/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-124-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","72189-124-72","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","DIRECT RX","72189-124","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/14/2020","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-124-72)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","72189-134-72","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","DIRECT RX","72189-134","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2020","N/A","ANDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-134-72)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","72189-134-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","DIRECT RX","72189-134","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-134-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","72189-134-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","DIRECT RX","72189-134","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-134-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","72189-134-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","DIRECT RX","72189-134","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/15/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-134-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72241-020-17","75 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Modavar Pharmaceuticals LLC","72241-020","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","10 BLISTER PACK in 1 CARTON (72241-020-17)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72241-020-11","75 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Modavar Pharmaceuticals LLC","72241-020","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (72241-020-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72241-020-05","75 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Modavar Pharmaceuticals LLC","72241-020","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (72241-020-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72241-021-05","100 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Modavar Pharmaceuticals LLC","72241-021","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","100 TABLET, FILM COATED in 1 BOTTLE (72241-021-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72241-021-11","100 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Modavar Pharmaceuticals LLC","72241-021","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","1000 TABLET, FILM COATED in 1 BOTTLE (72241-021-11)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72241-021-17","100 mg/1","TABLET, FILM COATED","ORAL","ANDA208606","Modavar Pharmaceuticals LLC","72241-021","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/12/2023","N/A","ANDA","10 BLISTER PACK in 1 CARTON (72241-021-17)  / 10 TABLET, FILM COATED in 1 BLISTER PACK","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"buPropion Hydrochloride","72516-035-03","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211200","Oryza pharmaceuticals Inc.","72516-035","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"buPropion Hydrochloride","72516-035-09","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211200","Oryza pharmaceuticals Inc.","72516-035","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"buPropion Hydrochloride","72516-035-50","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211200","Oryza pharmaceuticals Inc.","72516-035","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/01/2020","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-50)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"buPropion Hydrochloride","72516-036-03","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211200","Oryza pharmaceuticals Inc.","72516-036","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/06/2019","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-036-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"buPropion Hydrochloride","72516-036-09","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211200","Oryza pharmaceuticals Inc.","72516-036","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/06/2019","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-036-09)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"buPropion Hydrochloride","72516-036-50","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA211200","Oryza pharmaceuticals Inc.","72516-036","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/06/2019","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-036-50)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","72789-070-30","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","PD-Rx Pharmaceuticals, Inc.","72789-070","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/26/2020","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-070-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72789-070-90","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","PD-Rx Pharmaceuticals, Inc.","72789-070","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/07/2024","N/A","ANDA","90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-070-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72789-112-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","PD-Rx Pharmaceuticals, Inc.","72789-112","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/03/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-112-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72789-120-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210081","PD-Rx Pharmaceuticals, Inc.","72789-120","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/23/2020","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-120-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","72789-158-60","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","PD-Rx Pharmaceuticals, Inc.","72789-158","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/18/2021","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-158-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE","72789-301-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","PD-Rx Pharmaceuticals, Inc.","72789-301","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/22/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-301-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","72789-377-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","PD-Rx Pharmaceuticals, Inc.","72789-377","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/30/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-377-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"bupropion Hydrochloride","72789-544-90","100 mg/1","TABLET","ORAL","ANDA206975","PD-Rx Pharmaceuticals, Inc.","72789-544","bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/05/2026","N/A","ANDA","90 TABLET in 1 BOTTLE, PLASTIC (72789-544-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","76282-480-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Exelan Pharmaceuticals Inc.","76282-480","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76282-480-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Exelan Pharmaceuticals Inc.","76282-480","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76282-480-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Exelan Pharmaceuticals Inc.","76282-480","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/01/2019","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76282-481-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Exelan Pharmaceuticals Inc.","76282-481","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76282-481-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Exelan Pharmaceuticals Inc.","76282-481","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/10/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76282-481-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Exelan Pharmaceuticals Inc.","76282-481","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/12/2017","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-812-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Asclemed USA, Inc.","76420-812","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/07/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-812-60","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Asclemed USA, Inc.","76420-812","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/07/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-812-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Asclemed USA, Inc.","76420-812","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/07/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-812-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Asclemed USA, Inc.","76420-812","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/07/2024","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-812-01","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","Asclemed USA, Inc.","76420-812","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","05/07/2024","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-923-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Asclemed USA, Inc.","76420-923","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2025","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-923-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Asclemed USA, Inc.","76420-923","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2025","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-923-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Asclemed USA, Inc.","76420-923","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-923-01","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Asclemed USA, Inc.","76420-923","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2025","N/A","ANDA","100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-01)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","76420-923-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA077715","Asclemed USA, Inc.","76420-923","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/25/2025","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (76420-923-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","77771-144-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","RADHA PHARMACEUTICALS, INC.","77771-144","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/26/2022","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-144-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-144-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","RADHA PHARMACEUTICALS, INC.","77771-144","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/26/2022","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-144-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-144-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","RADHA PHARMACEUTICALS, INC.","77771-144","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/26/2022","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-144-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-145-30","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","RADHA PHARMACEUTICALS, INC.","77771-145","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/26/2022","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-145-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-145-05","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","RADHA PHARMACEUTICALS, INC.","77771-145","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/26/2022","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-145-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-145-90","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","RADHA PHARMACEUTICALS, INC.","77771-145","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/26/2022","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-145-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-174-60","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Radha Pharmaceuticals, Inc.","77771-174","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2021","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-174-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-174-05","100 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Radha Pharmaceuticals, Inc.","77771-174","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2021","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-174-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-175-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Radha Pharmaceuticals, Inc.","77771-175","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2021","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-175-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-175-05","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Radha Pharmaceuticals, Inc.","77771-175","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2021","N/A","ANDA","500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-175-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","77771-176-60","200 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Radha Pharmaceuticals, Inc.","77771-176","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/15/2021","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-176-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride","80425-0300-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Advanced Rx Pharmacy of Tennessee, LLC","80425-0300","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/06/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0300-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","80425-0300-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Advanced Rx Pharmacy of Tennessee, LLC","80425-0300","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/06/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0300-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride","80425-0300-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Advanced Rx Pharmacy of Tennessee, LLC","80425-0300","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/06/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0300-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","80425-0461-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Advanced Rx of Tennessee, LLC","80425-0461","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/18/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0461-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","80425-0461-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Advanced Rx of Tennessee, LLC","80425-0461","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/18/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0461-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE","80425-0461-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210497","Advanced Rx of Tennessee, LLC","80425-0461","BUPROPION HYDROCHLORIDE","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/18/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0461-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","80425-0468-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Advanced Rx of Tennessee, LLC","80425-0468","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0468-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","80425-0468-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Advanced Rx of Tennessee, LLC","80425-0468","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0468-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","80425-0468-2","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA207224","Advanced Rx of Tennessee, LLC","80425-0468","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/01/2025","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0468-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","80425-0539-2","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Advanced Rx of Tennessee, LLC","80425-0539","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2025","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80425-0539-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","80425-0539-1","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Advanced Rx of Tennessee, LLC","80425-0539","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2025","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80425-0539-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","80425-0539-3","300 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Advanced Rx of Tennessee, LLC","80425-0539","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2025","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80425-0539-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82009-051-05","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Quallent Pharmaceuticals Health LLC","82009-051","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/07/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (82009-051-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82009-052-05","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA090693","Quallent Pharmaceuticals Health LLC","82009-052","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/07/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (82009-052-05)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82804-013-60","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Proficient Rx LP","82804-013","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/21/2023","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82804-013-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82804-013-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Proficient Rx LP","82804-013","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/21/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82804-013-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82804-013-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206556","Proficient Rx LP","82804-013","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","09/21/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82804-013-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82804-080-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Proficient Rx LP","82804-080","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/05/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82804-080-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82804-080-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Proficient Rx LP","82804-080","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/05/2024","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82804-080-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82804-080-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA210015","Proficient Rx LP","82804-080","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/05/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82804-080-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82804-123-30","100 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Proficient Rx LP","82804-123","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/15/2024","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (82804-123-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82804-127-30","75 mg/1","TABLET, FILM COATED","ORAL","ANDA076143","Proficient Rx LP","82804-127","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/18/2024","N/A","ANDA","30 TABLET, FILM COATED in 1 BOTTLE (82804-127-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","82868-019-90","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Northwind Health Company, LLC","82868-019","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/02/2025","N/A","ANDA","90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-019-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","82868-019-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Northwind Health Company, LLC","82868-019","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/19/2023","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-019-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","82868-019-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Northwind Health Company, LLC","82868-019","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/14/2024","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-019-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","82868-019-96","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","Northwind Health Company, LLC","82868-019","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","02/19/2024","N/A","ANDA","180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-019-96)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride","83008-082-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA207479","Quality Care Products, LLC","83008-082","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/28/2024","12/31/2026","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83008-082-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","N/A"
"Bupropion Hydrochloride","85534-0006-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","HAWAII REPACK, INC.","85534-0006","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/11/2025","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","85534-0006-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","HAWAII REPACK, INC.","85534-0006","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/11/2025","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","85534-0006-9","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","HAWAII REPACK, INC.","85534-0006","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/11/2025","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-9)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","85534-0006-6","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","HAWAII REPACK, INC.","85534-0006","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/11/2025","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-6)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion Hydrochloride","85534-0006-5","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA077285","HAWAII REPACK, INC.","85534-0006","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/11/2025","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (85534-0006-5)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","43598-863-60","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206122","Dr. Reddy's Laboratories Inc","43598-863","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2016","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","43598-863-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206122","Dr. Reddy's Laboratories Inc","43598-863","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2016","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","43598-863-10","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206122","Dr. Reddy's Laboratories Inc","43598-863","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/17/2016","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-10)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","50090-5101-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206122","A-S Medication Solutions","50090-5101","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/13/2020","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","50090-5101-0","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206122","A-S Medication Solutions","50090-5101","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/13/2020","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-0)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-877-07","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-877","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-877-02","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-877","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-877-12","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-877","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-12)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-877-03","100 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-877","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-878-02","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-878","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-878-12","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-878","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-12)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-878-03","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-878","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-878-07","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-878","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-879-07","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-879","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-879-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-879-02","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-879","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-879-02)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-879-12","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-879","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-879-12)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (SR)","69097-879-03","200 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA206674","Cipla USA Inc.,","69097-879","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","07/25/2016","N/A","ANDA","60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-879-03)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride (XL)","0527-2415-43","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Lannett Company Inc.","0527-2415","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-43)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","0527-2415-46","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Lannett Company Inc.","0527-2415","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-46)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","0527-2415-32","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Lannett Company Inc.","0527-2415","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-32)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","0527-2415-41","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Lannett Company Inc.","0527-2415","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-41)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","0527-2430-41","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Lannett Company Inc.","0527-2430","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2430-41)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","0527-2430-43","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Lannett Company Inc.","0527-2430","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2430-43)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","0527-2430-32","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Lannett Company Inc.","0527-2430","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2430-32)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","0527-2430-46","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Lannett Company Inc.","0527-2430","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/31/2022","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2430-46)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE (XL)","62135-875-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Chartwell RX, LLC","62135-875","BUPROPION HYDROCHLORIDE (XL)","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/28/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 PACKAGE (62135-875-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE (XL)","62135-876-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Chartwell RX, LLC","62135-876","BUPROPION HYDROCHLORIDE (XL)","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","03/28/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 PACKAGE (62135-876-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Bupropion hydrochloride (XL)","69680-157-93","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Vitruvias Therapeutics","69680-157","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-157-93)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","69680-157-92","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Vitruvias Therapeutics","69680-157","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-157-92)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","69680-157-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Vitruvias Therapeutics","69680-157","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-157-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","69680-157-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Vitruvias Therapeutics","69680-157","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-157-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","69680-158-92","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Vitruvias Therapeutics","69680-158","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-158-92)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","69680-158-90","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Vitruvias Therapeutics","69680-158","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-158-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","69680-158-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Vitruvias Therapeutics","69680-158","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-158-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion hydrochloride (XL)","69680-158-93","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Vitruvias Therapeutics","69680-158","Bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/10/2023","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-158-93)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride (XL)","83301-0024-4","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Mullan Pharmaceutical Inc.","83301-0024","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/17/2024","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0024-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride (XL)","83301-0024-3","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Mullan Pharmaceutical Inc.","83301-0024","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/17/2024","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0024-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride (XL)","83301-0024-2","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Mullan Pharmaceutical Inc.","83301-0024","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/17/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0024-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride (XL)","83301-0024-1","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Mullan Pharmaceutical Inc.","83301-0024","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/17/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0024-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride (XL)","83301-0025-4","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Mullan Pharmaceutical Inc.","83301-0025","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/17/2024","N/A","ANDA","1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0025-4)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride (XL)","83301-0025-1","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Mullan Pharmaceutical Inc.","83301-0025","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/17/2024","N/A","ANDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0025-1)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride (XL)","83301-0025-3","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Mullan Pharmaceutical Inc.","83301-0025","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/17/2024","N/A","ANDA","500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0025-3)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"Bupropion Hydrochloride (XL)","83301-0025-2","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","ANDA208652","Mullan Pharmaceutical Inc.","83301-0025","Bupropion Hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/17/2024","N/A","ANDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (83301-0025-2)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"BUPROPION HYDROCHLORIDE SR","72189-349-30","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","DirectRx","72189-349","BUPROPION HYDROCHLORIDE SR","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/09/2022","N/A","ANDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72189-349-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"BUPROPION HYDROCHLORIDE SR","72189-349-60","150 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","ANDA205794","DirectRx","72189-349","BUPROPION HYDROCHLORIDE SR","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","04/22/2022","N/A","ANDA","60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72189-349-60)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"Contrave","51267-890-99","90 mg/1,                         8  mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA200063","Nalpropion Pharmaceuticals LLC","51267-890","naltrexone hydrochloride and bupropion hydrochloride","BUPROPION HYDROCHLORIDE;  NALTREXONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","10/22/2014","N/A","NDA","120 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-99)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA],  Opioid Antagonist [EPC],  Opioid Antagonists [MoA]","N/A","No","12/31/2026"
"Contrave","51267-890-07","90 mg/1,                         8  mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA200063","Nalpropion Pharmaceuticals LLC","51267-890","naltrexone hydrochloride and bupropion hydrochloride","BUPROPION HYDROCHLORIDE;  NALTREXONE HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","01/14/2021","N/A","NDA","7 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA],  Opioid Antagonist [EPC],  Opioid Antagonists [MoA]","N/A","Yes","12/31/2026"
"Forfivo","24979-247-06","450 mg/1","TABLET, FILM COATED, EXTENDED RELEASE","ORAL","NDA022497","Upsher-Smith Laboratories, LLC","24979-247","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","12/15/2023","N/A","NDA","30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-247-06)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"WELLBUTRIN","0173-0135-55","150 mg/1","TABLET, FILM COATED","ORAL","NDA020358","GlaxoSmithKline LLC","0173-0135","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/15/1996","N/A","NDA","60 TABLET, FILM COATED in 1 BOTTLE (0173-0135-55)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"WELLBUTRIN","0173-0722-00","200 mg/1","TABLET, FILM COATED","ORAL","NDA020358","GlaxoSmithKline LLC","0173-0722","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","06/25/2002","N/A","NDA","60 TABLET, FILM COATED in 1 BOTTLE (0173-0722-00)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"WELLBUTRIN","0173-0947-55","100 mg/1","TABLET, FILM COATED","ORAL","NDA020358","GlaxoSmithKline LLC","0173-0947","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","11/15/1996","N/A","NDA","60 TABLET, FILM COATED in 1 BOTTLE (0173-0947-55)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2026"
"WELLBUTRIN","0187-0730-30","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA021515","Bausch Health US LLC","0187-0730","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2003","N/A","NDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"WELLBUTRIN","0187-0730-90","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA021515","Bausch Health US LLC","0187-0730","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2003","N/A","NDA","90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-90)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"WELLBUTRIN","0187-0730-07","150 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA021515","Bausch Health US LLC","0187-0730","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2003","N/A","NDA","7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"WELLBUTRIN","0187-0731-07","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA021515","Bausch Health US LLC","0187-0731","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2003","N/A","NDA","7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0731-07)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"WELLBUTRIN","0187-0731-30","300 mg/1","TABLET, EXTENDED RELEASE","ORAL","NDA021515","Bausch Health US LLC","0187-0731","bupropion hydrochloride","BUPROPION HYDROCHLORIDE","HUMAN PRESCRIPTION DRUG","08/29/2003","N/A","NDA","30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0731-30)","Aminoketone [EPC],  Dopamine Uptake Inhibitors [MoA],  Increased Dopamine Activity [PE],  Increased Norepinephrine Activity [PE],  Norepinephrine Uptake Inhibitors [MoA]","N/A","No","12/31/2027"
"WELLBUTRIN SR (U)","61919-036-60"," "," "," "," ","DIRECT RX"," "," "," "," "," ","N/A"," "," ","N/A","N/A","N/A"," "